[1] TORRE L A,BRAY F,SIEGEL R L. Global cancer statistics,2012[J]. CA Cancer J Clin,2015,65(2):87
[2] NASIM F,SABATH B F,EAPEN G A. Lung Cancer[J]. Med Clin North Am,2019,103(3):463
[3] MILLER K D,SIEGEL R L,LIN C C,et al. Cancer treatment and survivorship statistics,2016[J]. CA Cancer J Clin,2016,66(4):271
[4] HERBST R S,MORGENSZTERN D,Boshoff C.The biology and management of non-small cell lung cancer[J]. Nature,2018,553(7689):446
[5] BUCHER P,ERDMANN T,GRONDONA P,et al. Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma[J]. Blood,2020,135(2):121
[6] LIU Y,LIANG T,QIU X,et al. Down-regulation of NFATc1 suppresses proliferation,migration,invasion,and warburg effect in prostate cancer cells[J]. Med Sci Monit,2019,25:1572
[7] XU W,GU J,REN Q,et al. NFATc1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway[J]. Tumour Biol,2016,37(4):4493
[8] MANDA K R,TRIPATHI P,HSI A C,et al. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence[J]. Oncogene,2016,35(25):3282
[9] XIN B,JI K Q,LIU Y S,et al. NFAT Overexpression correlates with CA72-4 and poor prognosis of ovarian clear-cell carcinoma subtype[J]. Reprod Sci,2020,10.1007/s43032-020-00368-3
[10] WANG L,WANG Z,LI J,et al. NFATc1 activation promotes the invasion of U251 human glioblastoma multiforme cells through COX-2[J]. Int J Mol Med,2015,35(5):1333
[11] 朱婷婷. ZIP4与肿瘤生物学行为的研究进展[J]. 天津医科大学学报,2020,26(2):183
[12] DONG Y,SUN Y,HUANG Y,et al. Depletion of MLKL inhibits invasion of radioresistant nasopharyngeal carcinoma cells by suppressing epithelial-mesenchymal transition[J]. Ann Transl Med,2019,7(23):741
[13] LI L,DUAN Z,YU J. NFATc1 regulates cell proliferation,migration,and invasion of ovarian cancer SKOV3 cells in vitro and in vivo[J]. Oncol Rep,2016,36:918
[14] KAWAHARA T,KASHIWAGI E,IDE H,et al. The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation,migration,and invasion[J]. Prostate,2015,75: 573
[15] HE Y,XIE H,YU P,et al. FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells[J]. Cancer Chemother Pharmacol,2018,82(6):1049
[16] WANG B,TANG Z,GONG H,et al. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer[J]. Biosci Rep,2017,37(6):BSR20171092
[17] XIAO G,LI Y,WANG M,et al. FBXW7 suppresses epithelial-mesenchymal transition and chemo-resistance of non-small-cell lung cancer cells by targeting snail for ubiquitin-dependent degradation[J]. Cell Prolif,2018,51(5):e12473
[1]马淑晶,张晓燕,徐亚洁,等.青蒿琥酯通过上调神经酰胺抑制肝星状细胞增殖并诱导其凋亡[J].天津医科大学学报,2014,20(04):253.
MA Shu-jing,ZHANG Xiao-yan,XU Ya-jie,et al.Artesunate inhibits the proliferation of hepatic stellate cells and induces apoptosis by upregulating ceramide[J].Journal of Tianjin Medical University,2014,20(05):253.
[2]王 勇,陈雅婧 综述,岳 丹审校.YB-1对肿瘤增殖调控的研究进展[J].天津医科大学学报,2014,20(04):332.
[3]伦淑敏.肌细胞增强因子2A基因真核表达质粒的构建及对乳腺癌细胞MCF-7增殖能力的影响[J].天津医科大学学报,2014,20(06):429.
LUN Shu-min.Construction of myocyte enhancer factor 2A eukaryotic expression plasmid and effects on cell proliferation in breast cancer cell line MCF7[J].Journal of Tianjin Medical University,2014,20(05):429.
[4]孙秀梅,张 飞,田 然,等.Nanog表达上调促进乳腺癌细胞MCF-7的增殖和侵袭[J].天津医科大学学报,2014,20(06):421.
SUN Xiu-mei,ZHANG Fei,TIAN Ran,et al.Up-regulation of Nanog promotes cell proliferation and invasion in breast cancer cells MCF-7[J].Journal of Tianjin Medical University,2014,20(05):421.
[5]任宗娜.沉默Notch4基因对乳腺癌细胞系MDA-MB-231增殖和迁移侵袭能力的影响[J].天津医科大学学报,2015,21(06):469.
REN Zong-na.Inhibition effect of?silencing?? Notch4 gene on the proliferation and migration and invasion activity of? breast cancer cell line?MDA-MB-231[J].Journal of Tianjin Medical University,2015,21(05):469.
[6]姚 芳,张 鹏,王元国.5-杂氮-2′-脱氧胞苷上调CK13表达并抑制人肺鳞癌YTMLC-9细胞增殖[J].天津医科大学学报,2015,21(06):474.
YAO Fang,ZHANG Peng,WANG Yuan-guo. 5-Aza-2 ′-deoxycytidine inhibits human lung squamous carcinoma YTMLC-9 cell by epigenetically silenced CK13 gene in vitro [J].Journal of Tianjin Medical University,2015,21(05):474.
[7]周岩,宋伟杰,张飞,等.人附睾蛋白4在乳腺癌发生发展中的机制研究[J].天津医科大学学报,2015,21(06):466.
ZHOU Yan,SONG Wei-jie,ZHANG Fei,et al.Mechanism of human epididymis protein 4 in development and progression of breast cancer[J].Journal of Tianjin Medical University,2015,21(05):466.
[8]黄环静综述,冯玉梅审校.NF-κB信号通路促进乳腺癌细胞增殖和转移机制的研究进展[J].天津医科大学学报,2016,22(03):270.
[9]黄环静.慢病毒载体PLKO.1-shp65的构建及在乳腺癌细胞MDA-MB-231中功能的研究[J].天津医科大学学报,2016,22(05):386.
HUANG Huan-jing.Construction of p65 shRNA knockdown vector and its effect on breast cancer cell MDA-MB-231[J].Journal of Tianjin Medical University,2016,22(05):386.
[10]文明明,马跃美,赵秀兰,等.炎症因子IL-23 对黑色素瘤细胞增殖侵袭及双向分化的影响[J].天津医科大学学报,2017,23(04):295.
WEN Ming-ming,MA Yue-mei,ZHAO Xiu-lan,et al.Effects of IL-23 on the herin proliferation,invasion and bi-differentiation? of melanoma cells[J].Journal of Tianjin Medical University,2017,23(05):295.